Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued New evidence-based clinical practice guidelines have been issued for the prophylaxis of venous thromboembolism (VTE) in nonsurgical ...

Two new studies on the prophylaxis of venous thromboembolism have thrust the subject into the spotlight once more. An editorialist says the use of VTE prophylaxis is woefully inadequate worldwide ...

The increased risk of venous thromboembolism in patients with cancer is well known. Depending on the source, the incidence varies partly due to different diagnostic methods, but ranges up to 20%.

Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992;305:567-574. Crossref. PubMed. Google Scholar. Information & Authors Information Published In.

PHILADELPHIA (CBS) - The term is VTE prophylaxis and although it might sound like alphabet soup it has become a very important part of hospital care. The reason why this is important is because ...

Given the dearth of randomized controlled trials available with regard to VTE in patients with multiple myeloma, a simplified, expert-based approach to prophylaxis at various stages of MM, treated ...

Hospitalists achieving ACCP-compliance VTE prophylaxis rates of 80% to 100% were paid an additional $0.125 to $0.50 per relative value unit of work.

Approximately 65% of patients with either low or high risk for venous thromboembolism events received excessive prophylaxis, according to findings published in JAMA Internal Medicine.“National ...

Prophylaxis against venous thromboembolism should be considered in patients with metastatic disease, a history of life-threatening pulmonary embolism or extensive lower-extremity deep-vein ...

A new set of guidelines, developed by AATS and ESTS (European Society for Thoracic Surgery) presented today at the AATS 101st Annual Meeting, recommends a 30-day course of Venous Thromboembolism ...

HOUSTON --The risk of re-bleeding after intracranial hemorrhage did not increase when patients received early prophylaxis for venous thromboembolism (VTE), a retrospective review showed.

Bevyxxa Approved for Prophylaxis of Venous Thromboembolism. Da Hee Han, PharmD | June 23, 2017 ...